HIV mutation literature information.


  Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China.
 PMID: 28099515       2017       PloS one
Discussion: Among 20 significant death-associated polymorphisms, 13 (65%) polymorphisms (E6D, Q18H, E35D, S37N, T39A, K43E, S68N,
Discussion: For example, T39A and K43E had three (M41L, K43E, and M184V) and seven (D67N, L74V, K101E, L210W, M184V, T215Y, and E224D) target drug resistance mutations, respectively.


  Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.
 PMID: 26850643       2016       Nucleic acids research
Result: Sequence comparisons of HIV-1 positive naive and HAART treated patients revealed a correlation between K20R and 3TC resistance and an association with TAMs, while T39A appears to be associated with previous AZT and d4T treatment and with the development of TAMs.


  Transmitted HIV drug resistance in treatment-naive Romanian patients.
 PMID: 23592112       2013       Journal of medical virology
Result: The analysis of the RT gene also revealed many accessory mutations presented in all studied sequences, encountered most frequently at positions V35T, T39A, V60I, I135L, A272P, I293V.


  Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
 PMID: 22363673       2012       PloS one
Table: T39A


  Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.
 PMID: 22889300       2012       Retrovirology
Result: The frequency of accessory mutations such as T39A, H208Y and L228H was also significantly higher in the treated population compared with the naive group.
Table: T39A
Discussion: Among them, T39A, V179I, H208Y, K223E, L228H/R, R284K and V292I have been previously identified as secondary mutations associated with the accumulation of TAMs and with resistance to nucleoside analogues.


  Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase.
 PMID: 18271957       2008       Retrovirology
Introduction: These mutations include the K20R, V35M, T39A, E40F, K43E/Q/N, A98G, K122E, G196E, E203K/D, H208Y, D218E, H221Y, K223E/Q and L228H/R changes.


  Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.
 PMID: 17417971       2007       Retrovirology
Table: T39A


  HIV-1 subtype B protease and reverse transcriptase amino acid covariation.
 PMID: 17500586       2007       PLoS computational biology
Method: Recently described accessory NRTI mutations included T39A, K43E/Q/N, E44D/A, V118I, E203K, H208, D218E, H221Y, K223Q, and L228H/R.


  Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors.
 PMID: 16299731       2006       Journal of medical virology
Abstract: A correlation was found between K20R and lamivudine resistance (P = 0.006) while T39A (P = 0.005), K43EQN (<0.001), E203KD (P = 0.010), and H208Y (P = < 0.001) seemed to be associated with a previous use of zidovudine and stavudine and with the development of thymidine analog resistance.
Abstract: The mutations involving 10 of these positions were associated with a reduced susceptibility to antiretroviral drugs; K20R, T39A, K43EQN, E203KD, H208Y, and D218E were correlated with NRTI resistance while mutations  PMID: 16809324       2006       Journal of virology
Abstract: In particular, T39A, K43E/Q, K122E, E203K, and H208Y clustered with the nucleoside analogue mutation 1 cluster (NAM1; M41L+L210W+T215Y).



Browser Board

 Co-occurred Entities




   Filtrator